Our entirely rewritten application addresses the lacrimal/corneal axis as a fundamental regulator of ocular health. We seek a global understanding of how lacrimal acinar cell secretory control is governed and downstream consequences. Modulation of basal and reflex tear secretion is complex, largely unexplored and reversible; and plays into the enigmatic etiology of Dry Eye syndromes for which basal and reflex tearing capacity is often differentially deficient. Underlying main lacrimal gland 'basal' and 'reflex' tearing (terms that describe output at the ocular surface) are the acinar cell 'constitutive', 'constitutive-like', 'minor regulated' (basal) as well as 'major regulated' (reflex) secretory pathways - each with particular characteristics defined for the most part in other exocrine organs such as the parotid. Hypothetically possible is a receptor-mediated autocrine feedback loop(s) in which secretory product(s) released from one secretory pathway enhance or diminish secretion from another pathway, a potentially sensitive arrangement offering a novel framework for studying lacrimal hyposecretion in Dry Eye. Recently we discovered lacritin, an autocrine enhancer of lacrimal acinar cell basal secretion (Sanghi et al, J. Mol. Biol. '01; cover issue). Lacritin is highly conserved and released from lacrimal acinar cells by the major regulated pathway. It enhances basal tear secretion in a dose dependent manner, and rapidly activates both low amplitude calcium signaling and tyrosine phosphorylation. Lacritin also promotes the proliferation of downstream ductal cells and calcium signaling by corneal epithelial cells. Estimated cell binding affinity is 0.03 - 0.07 nM (versus NGF [0.01 - 1 nM], EGF [0.2 nM], PDGF [0.4 - 0. 7 nM]). Expression studies suggest that the lacritin gene is one of the most lacrimal gland-specific described. Our working hypothesis is that lacritin release stimulates the minor regulated pathway in a G -protein coupled receptor dependent manner, and that ligation of the same receptor in ductal and corneal epithelial cells regulates cell turnover.
Our specific aims are therefore: (1) to identify and characterize how lacritin contacts target cell surfaces, (2) to clarify the identity of the lacritin-dependent secretory pathway, its mechanism of activation and significance, and (3) to elucidate lacritin's downstream ductal and ocular surface role.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
3R01EY013143-02S2
Application #
6872595
Study Section
Visual Sciences A Study Section (VISA)
Program Officer
Fisher, Richard S
Project Start
2002-08-01
Project End
2007-07-31
Budget Start
2003-09-01
Budget End
2004-07-31
Support Year
2
Fiscal Year
2004
Total Cost
$2,213
Indirect Cost
Name
University of Virginia
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Karnati, Roy; Talla, Venu; Peterson, Katherine et al. (2016) Lacritin and other autophagy associated proteins in ocular surface health. Exp Eye Res 144:4-13
McKown, Robert L; Coleman Frazier, Erin V; Zadrozny, Kaneil K et al. (2014) A cleavage-potentiated fragment of tear lacritin is bactericidal. J Biol Chem 289:22172-82
Vijmasi, Trinka; Chen, Feeling Y T; Balasubbu, Suganthalakshmi et al. (2014) Topical administration of lacritin is a novel therapy for aqueous-deficient dry eye disease. Invest Ophthalmol Vis Sci 55:5401-9
Feng, Mary M; Baryla, Julia; Liu, Hong et al. (2014) Cytoprotective effect of lacritin on human corneal epithelial cells exposed to benzalkonium chloride in vitro. Curr Eye Res 39:604-10
Zhang, Yinghui; Wang, Ningning; Raab, Ronald W et al. (2013) Targeting of heparanase-modified syndecan-1 by prosecretory mitogen lacritin requires conserved core GAGAL plus heparan and chondroitin sulfate as a novel hybrid binding site that enhances selectivity. J Biol Chem 288:12090-101
McKown, Robert L; Raab, Ronald W; Kachelries, Patricia et al. (2013) Conserved regional 3' grouping of rare codons in the coding sequence of ocular prosecretory mitogen lacritin. Invest Ophthalmol Vis Sci 54:1979-87
Karnati, Roy; Laurie, Diane E; Laurie, Gordon W (2013) Lacritin and the tear proteome as natural replacement therapy for dry eye. Exp Eye Res 117:39-52
Velez V, Francisco; Romano, Jeffrey A; McKown, Robert L et al. (2013) Tissue transglutaminase is a negative regulator of monomeric lacritin bioactivity. Invest Ophthalmol Vis Sci 54:2123-32
Wang, Ningning; Zimmerman, Keith; Raab, Ronald W et al. (2013) Lacritin rescues stressed epithelia via rapid forkhead box O3 (FOXO3)-associated autophagy that restores metabolism. J Biol Chem 288:18146-61
Laurie, Diane E; Splan, Rebecca K; Green, Kari et al. (2012) Detection of prosecretory mitogen lacritin in nonprimate tears primarily as a C-terminal-like fragment. Invest Ophthalmol Vis Sci 53:6130-6

Showing the most recent 10 out of 21 publications